Looking for volunteers
The SEQUENCE Trial
NCT06676956 · Northwestern University · Updated 25 Aug 2026
- What is being tested
- Linear EBUS first; Robotic-assisted bronchoscopy first
- For
- Pulmonary Nodules
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 320 people. The full rules are on the registry page.
- Where
- United States (5 sites)
- When
- Starts or started 10 Nov 2024, ends Dec 2027. Registered 6 Nov 2024.
- Results
- None posted yet.
In the researchers' words
This study will randomize participants undergoing a bronchoscopic biopsy of a peripheral pulmonary nodule for their standard of care to receive robotic-assisted bronchoscopy (RaB) and then staging linear endobronchial ultrasounnd (EBUS) OR staging linear EBUS first, followed by RaB. The goal of this study is to set the standard for optimizing the sequence of bronchoscopic procedures in patients at risk for early-stage malignancy.
Sites
- University of California, DavisSacramento, California, United States
- Northwestern UniversityChicago, Illinois, United States
- Johns Hopkins UniversityBaltimore, Maryland, United States
- University of MichiganAnn Arbor, Michigan, United States
- University of North Carolina, Chapel HillChapel Hill, North Carolina, United States